transcription activator-like effector nucleases

The review identifies long-term genetic stability, scalability, and off-target effects as challenges for genetically engineered tissues.

We address the field's challenges, including long-term genetic stability, scalability, and off-target effects, while also considering the ethical implications and evolving regulatory landscape of genetically engineered tissues.

The review describes base editing and synthetic genetic circuits as emerging technologies explored for creating smart tissues capable of dynamic environmental responses.

Emerging technologies in genetic engineering, including base editing and synthetic genetic circuits, have been explored for their potential to create "smart" tissues capable of dynamic environmental responses.

The review states that integrating genetic engineering with 3D-bioprinting, microfluidics, and smart biomaterials expands the horizons of complex tissue fabrication.

We further investigate the integration of these genetic approaches with emerging technologies such as 3D-bioprinting, microfluidics, and smart biomaterials, which collectively expand the horizons of complex tissue fabrication.

The review examines CRISPR-Cas9, TALENs, and synthetic biology as genetic engineering approaches for modifying cellular behaviors and functions in tissue engineering.

We critically examine the application of advanced genetic engineering techniques, including CRISPR-Cas9, TALENs, and synthetic biology, in modifying cellular behaviors and functions for tissue engineering.

By 2013, CRISPR/Cas9 systems had been engineered to allow gene editing in mammalian cells.

By 2013, CRISPR/Cas9 systems had been engineered to allow gene editing in mammalian cells.

By 2013, CRISPR/Cas9 systems had been engineered to allow gene editing in mammalian cells.

By 2013, CRISPR/Cas9 systems had been engineered to allow gene editing in mammalian cells.

By 2013, CRISPR/Cas9 systems had been engineered to allow gene editing in mammalian cells.

By 2013, CRISPR/Cas9 systems had been engineered to allow gene editing in mammalian cells.

By 2013, CRISPR/Cas9 systems had been engineered to allow gene editing in mammalian cells.

By 2013, CRISPR/Cas9 systems had been engineered to allow gene editing in mammalian cells.

By 2013, CRISPR/Cas9 systems had been engineered to allow gene editing in mammalian cells.

By 2013, CRISPR/Cas9 systems had been engineered to allow gene editing in mammalian cells.

By 2013, CRISPR/Cas9 systems had been engineered to allow gene editing in mammalian cells.

By 2013, CRISPR/Cas9 systems had been engineered to allow gene editing in mammalian cells.

By 2013, CRISPR/Cas9 systems had been engineered to allow gene editing in mammalian cells.

By 2013, CRISPR/Cas9 systems had been engineered to allow gene editing in mammalian cells.

CRISPR/Cas9 and related systems are described as designer nucleases of choice because of ease of design, low cytotoxicity, and increased efficiency.

The ease of design, low cytotoxicity, and increased efficiency have made CRISPR/Cas9 and its related systems the designer nucleases of choice for many.

CRISPR/Cas9 and related systems are described as designer nucleases of choice because of ease of design, low cytotoxicity, and increased efficiency.

The ease of design, low cytotoxicity, and increased efficiency have made CRISPR/Cas9 and its related systems the designer nucleases of choice for many.

CRISPR/Cas9 and related systems are described as designer nucleases of choice because of ease of design, low cytotoxicity, and increased efficiency.

The ease of design, low cytotoxicity, and increased efficiency have made CRISPR/Cas9 and its related systems the designer nucleases of choice for many.

CRISPR/Cas9 and related systems are described as designer nucleases of choice because of ease of design, low cytotoxicity, and increased efficiency.

The ease of design, low cytotoxicity, and increased efficiency have made CRISPR/Cas9 and its related systems the designer nucleases of choice for many.

CRISPR/Cas9 and related systems are described as designer nucleases of choice because of ease of design, low cytotoxicity, and increased efficiency.

The ease of design, low cytotoxicity, and increased efficiency have made CRISPR/Cas9 and its related systems the designer nucleases of choice for many.

CRISPR/Cas9 and related systems are described as designer nucleases of choice because of ease of design, low cytotoxicity, and increased efficiency.

The ease of design, low cytotoxicity, and increased efficiency have made CRISPR/Cas9 and its related systems the designer nucleases of choice for many.

CRISPR/Cas9 and related systems are described as designer nucleases of choice because of ease of design, low cytotoxicity, and increased efficiency.

The ease of design, low cytotoxicity, and increased efficiency have made CRISPR/Cas9 and its related systems the designer nucleases of choice for many.

ZFN and TALEN provided sequence-specific gene-editing capacity but their broad utility was limited by laborious nuclease design and synthesis, limited target choices, and poor editing efficiency.

While these approaches provided sequence-specific gene-editing capacity, the laborious process of designing and synthesizing recombinant nucleases to recognize a specific target sequence, combined with limited target choices and poor editing efficiency, ultimately minimized the broad utility of these systems.

ZFN and TALEN provided sequence-specific gene-editing capacity but their broad utility was limited by laborious nuclease design and synthesis, limited target choices, and poor editing efficiency.

While these approaches provided sequence-specific gene-editing capacity, the laborious process of designing and synthesizing recombinant nucleases to recognize a specific target sequence, combined with limited target choices and poor editing efficiency, ultimately minimized the broad utility of these systems.

ZFN and TALEN provided sequence-specific gene-editing capacity but their broad utility was limited by laborious nuclease design and synthesis, limited target choices, and poor editing efficiency.

While these approaches provided sequence-specific gene-editing capacity, the laborious process of designing and synthesizing recombinant nucleases to recognize a specific target sequence, combined with limited target choices and poor editing efficiency, ultimately minimized the broad utility of these systems.

ZFN and TALEN provided sequence-specific gene-editing capacity but their broad utility was limited by laborious nuclease design and synthesis, limited target choices, and poor editing efficiency.

While these approaches provided sequence-specific gene-editing capacity, the laborious process of designing and synthesizing recombinant nucleases to recognize a specific target sequence, combined with limited target choices and poor editing efficiency, ultimately minimized the broad utility of these systems.

ZFN and TALEN provided sequence-specific gene-editing capacity but their broad utility was limited by laborious nuclease design and synthesis, limited target choices, and poor editing efficiency.

While these approaches provided sequence-specific gene-editing capacity, the laborious process of designing and synthesizing recombinant nucleases to recognize a specific target sequence, combined with limited target choices and poor editing efficiency, ultimately minimized the broad utility of these systems.

ZFN and TALEN provided sequence-specific gene-editing capacity but their broad utility was limited by laborious nuclease design and synthesis, limited target choices, and poor editing efficiency.

While these approaches provided sequence-specific gene-editing capacity, the laborious process of designing and synthesizing recombinant nucleases to recognize a specific target sequence, combined with limited target choices and poor editing efficiency, ultimately minimized the broad utility of these systems.

ZFN and TALEN provided sequence-specific gene-editing capacity but their broad utility was limited by laborious nuclease design and synthesis, limited target choices, and poor editing efficiency.

While these approaches provided sequence-specific gene-editing capacity, the laborious process of designing and synthesizing recombinant nucleases to recognize a specific target sequence, combined with limited target choices and poor editing efficiency, ultimately minimized the broad utility of these systems.

CRISPR and Cas proteins were identified as part of a microbial adaptive immune system that targets phage DNA to fight bacteriophage reinfection.

CRISPR and the CRISPR-associated (Cas) proteins were identified as part of the microbial adaptive immune system, by targeting phage DNA, to fight bacteriophage reinfection.

CRISPR and Cas proteins were identified as part of a microbial adaptive immune system that targets phage DNA to fight bacteriophage reinfection.

CRISPR and the CRISPR-associated (Cas) proteins were identified as part of the microbial adaptive immune system, by targeting phage DNA, to fight bacteriophage reinfection.

CRISPR and Cas proteins were identified as part of a microbial adaptive immune system that targets phage DNA to fight bacteriophage reinfection.

CRISPR and the CRISPR-associated (Cas) proteins were identified as part of the microbial adaptive immune system, by targeting phage DNA, to fight bacteriophage reinfection.

CRISPR and Cas proteins were identified as part of a microbial adaptive immune system that targets phage DNA to fight bacteriophage reinfection.

CRISPR and the CRISPR-associated (Cas) proteins were identified as part of the microbial adaptive immune system, by targeting phage DNA, to fight bacteriophage reinfection.

CRISPR and Cas proteins were identified as part of a microbial adaptive immune system that targets phage DNA to fight bacteriophage reinfection.

CRISPR and the CRISPR-associated (Cas) proteins were identified as part of the microbial adaptive immune system, by targeting phage DNA, to fight bacteriophage reinfection.

CRISPR and Cas proteins were identified as part of a microbial adaptive immune system that targets phage DNA to fight bacteriophage reinfection.

CRISPR and the CRISPR-associated (Cas) proteins were identified as part of the microbial adaptive immune system, by targeting phage DNA, to fight bacteriophage reinfection.

CRISPR and Cas proteins were identified as part of a microbial adaptive immune system that targets phage DNA to fight bacteriophage reinfection.

CRISPR and the CRISPR-associated (Cas) proteins were identified as part of the microbial adaptive immune system, by targeting phage DNA, to fight bacteriophage reinfection.

The review discusses various CRISPR systems and their broad utility in genome manipulation, including how CRISPR-controlled modification of DNA repair genes has advanced understanding of genome stability mechanisms.

In this review, we discuss the various CRISPR systems and their broad utility in genome manipulation. We will explore how CRISPR-controlled modifications have advanced our understanding of the mechanisms of genome stability, using the modulation of DNA repair genes as examples.

The review discusses various CRISPR systems and their broad utility in genome manipulation, including how CRISPR-controlled modification of DNA repair genes has advanced understanding of genome stability mechanisms.

In this review, we discuss the various CRISPR systems and their broad utility in genome manipulation. We will explore how CRISPR-controlled modifications have advanced our understanding of the mechanisms of genome stability, using the modulation of DNA repair genes as examples.

The review discusses various CRISPR systems and their broad utility in genome manipulation, including how CRISPR-controlled modification of DNA repair genes has advanced understanding of genome stability mechanisms.

In this review, we discuss the various CRISPR systems and their broad utility in genome manipulation. We will explore how CRISPR-controlled modifications have advanced our understanding of the mechanisms of genome stability, using the modulation of DNA repair genes as examples.

The review discusses various CRISPR systems and their broad utility in genome manipulation, including how CRISPR-controlled modification of DNA repair genes has advanced understanding of genome stability mechanisms.

In this review, we discuss the various CRISPR systems and their broad utility in genome manipulation. We will explore how CRISPR-controlled modifications have advanced our understanding of the mechanisms of genome stability, using the modulation of DNA repair genes as examples.

The review discusses various CRISPR systems and their broad utility in genome manipulation, including how CRISPR-controlled modification of DNA repair genes has advanced understanding of genome stability mechanisms.

In this review, we discuss the various CRISPR systems and their broad utility in genome manipulation. We will explore how CRISPR-controlled modifications have advanced our understanding of the mechanisms of genome stability, using the modulation of DNA repair genes as examples.

The review discusses various CRISPR systems and their broad utility in genome manipulation, including how CRISPR-controlled modification of DNA repair genes has advanced understanding of genome stability mechanisms.

In this review, we discuss the various CRISPR systems and their broad utility in genome manipulation. We will explore how CRISPR-controlled modifications have advanced our understanding of the mechanisms of genome stability, using the modulation of DNA repair genes as examples.

The review discusses various CRISPR systems and their broad utility in genome manipulation, including how CRISPR-controlled modification of DNA repair genes has advanced understanding of genome stability mechanisms.

In this review, we discuss the various CRISPR systems and their broad utility in genome manipulation. We will explore how CRISPR-controlled modifications have advanced our understanding of the mechanisms of genome stability, using the modulation of DNA repair genes as examples.

Zinc-finger nucleases, TALENs, and CRISPR/Cas9 are described as providing methods for gene knockout in sea urchins.

Recent advances in genome editing tools, such as zinc-finger nucleases, transcription activator-like effector-based nucleases and the ... CRISPR/Cas9 system, have provided methods for gene knockout in sea urchins.

Zinc-finger nucleases, TALENs, and CRISPR/Cas9 are described as providing methods for gene knockout in sea urchins.

Recent advances in genome editing tools, such as zinc-finger nucleases, transcription activator-like effector-based nucleases and the ... CRISPR/Cas9 system, have provided methods for gene knockout in sea urchins.

Zinc-finger nucleases, TALENs, and CRISPR/Cas9 are described as providing methods for gene knockout in sea urchins.

Recent advances in genome editing tools, such as zinc-finger nucleases, transcription activator-like effector-based nucleases and the ... CRISPR/Cas9 system, have provided methods for gene knockout in sea urchins.

Zinc-finger nucleases, TALENs, and CRISPR/Cas9 are described as providing methods for gene knockout in sea urchins.

Recent advances in genome editing tools, such as zinc-finger nucleases, transcription activator-like effector-based nucleases and the ... CRISPR/Cas9 system, have provided methods for gene knockout in sea urchins.

Zinc-finger nucleases, TALENs, and CRISPR/Cas9 are described as providing methods for gene knockout in sea urchins.

Recent advances in genome editing tools, such as zinc-finger nucleases, transcription activator-like effector-based nucleases and the ... CRISPR/Cas9 system, have provided methods for gene knockout in sea urchins.

Zinc-finger nucleases, TALENs, and CRISPR/Cas9 are described as providing methods for gene knockout in sea urchins.

Recent advances in genome editing tools, such as zinc-finger nucleases, transcription activator-like effector-based nucleases and the ... CRISPR/Cas9 system, have provided methods for gene knockout in sea urchins.

Zinc-finger nucleases, TALENs, and CRISPR/Cas9 are described as providing methods for gene knockout in sea urchins.

Recent advances in genome editing tools, such as zinc-finger nucleases, transcription activator-like effector-based nucleases and the ... CRISPR/Cas9 system, have provided methods for gene knockout in sea urchins.

Membrane-permeable vivo-MOs are described as enabling gene knockdown at later developmental stages in sea urchin studies.

The modification of MOs into a membrane-permeable form (vivo-MOs) has allowed gene knockdown at later developmental stages.

Membrane-permeable vivo-MOs are described as enabling gene knockdown at later developmental stages in sea urchin studies.

The modification of MOs into a membrane-permeable form (vivo-MOs) has allowed gene knockdown at later developmental stages.

Membrane-permeable vivo-MOs are described as enabling gene knockdown at later developmental stages in sea urchin studies.

The modification of MOs into a membrane-permeable form (vivo-MOs) has allowed gene knockdown at later developmental stages.

Membrane-permeable vivo-MOs are described as enabling gene knockdown at later developmental stages in sea urchin studies.

The modification of MOs into a membrane-permeable form (vivo-MOs) has allowed gene knockdown at later developmental stages.

Membrane-permeable vivo-MOs are described as enabling gene knockdown at later developmental stages in sea urchin studies.

The modification of MOs into a membrane-permeable form (vivo-MOs) has allowed gene knockdown at later developmental stages.

Membrane-permeable vivo-MOs are described as enabling gene knockdown at later developmental stages in sea urchin studies.

The modification of MOs into a membrane-permeable form (vivo-MOs) has allowed gene knockdown at later developmental stages.

Membrane-permeable vivo-MOs are described as enabling gene knockdown at later developmental stages in sea urchin studies.

The modification of MOs into a membrane-permeable form (vivo-MOs) has allowed gene knockdown at later developmental stages.

The biology of each genome-editing nuclease influences targeting potential, off-target cleavage spectrum, ease of use, and the types of recombination events produced at targeted double-strand breaks.

However, the underlying biology of each genome-editing nuclease influences the targeting potential, the spectrum of off-target cleavages, the ease-of-use, and the types of recombination events at targeted double-strand breaks.

The biology of each genome-editing nuclease influences targeting potential, off-target cleavage spectrum, ease of use, and the types of recombination events produced at targeted double-strand breaks.

However, the underlying biology of each genome-editing nuclease influences the targeting potential, the spectrum of off-target cleavages, the ease-of-use, and the types of recombination events at targeted double-strand breaks.

The biology of each genome-editing nuclease influences targeting potential, off-target cleavage spectrum, ease of use, and the types of recombination events produced at targeted double-strand breaks.

However, the underlying biology of each genome-editing nuclease influences the targeting potential, the spectrum of off-target cleavages, the ease-of-use, and the types of recombination events at targeted double-strand breaks.

The biology of each genome-editing nuclease influences targeting potential, off-target cleavage spectrum, ease of use, and the types of recombination events produced at targeted double-strand breaks.

However, the underlying biology of each genome-editing nuclease influences the targeting potential, the spectrum of off-target cleavages, the ease-of-use, and the types of recombination events at targeted double-strand breaks.

The biology of each genome-editing nuclease influences targeting potential, off-target cleavage spectrum, ease of use, and the types of recombination events produced at targeted double-strand breaks.

However, the underlying biology of each genome-editing nuclease influences the targeting potential, the spectrum of off-target cleavages, the ease-of-use, and the types of recombination events at targeted double-strand breaks.

The biology of each genome-editing nuclease influences targeting potential, off-target cleavage spectrum, ease of use, and the types of recombination events produced at targeted double-strand breaks.

However, the underlying biology of each genome-editing nuclease influences the targeting potential, the spectrum of off-target cleavages, the ease-of-use, and the types of recombination events at targeted double-strand breaks.

Targeting double-strand breaks to user-defined genomic locations greatly enhances DNA repair event rates relative to uncatalyzed events at the same sites.

By targeting double-strand breaks to user-defined locations, the rates of DNA repair events are greatly enhanced relative to un-catalyzed events at the same sites.

Targeting double-strand breaks to user-defined genomic locations greatly enhances DNA repair event rates relative to uncatalyzed events at the same sites.

By targeting double-strand breaks to user-defined locations, the rates of DNA repair events are greatly enhanced relative to un-catalyzed events at the same sites.

Targeting double-strand breaks to user-defined genomic locations greatly enhances DNA repair event rates relative to uncatalyzed events at the same sites.

By targeting double-strand breaks to user-defined locations, the rates of DNA repair events are greatly enhanced relative to un-catalyzed events at the same sites.

Targeting double-strand breaks to user-defined genomic locations greatly enhances DNA repair event rates relative to uncatalyzed events at the same sites.

By targeting double-strand breaks to user-defined locations, the rates of DNA repair events are greatly enhanced relative to un-catalyzed events at the same sites.

Targeting double-strand breaks to user-defined genomic locations greatly enhances DNA repair event rates relative to uncatalyzed events at the same sites.

By targeting double-strand breaks to user-defined locations, the rates of DNA repair events are greatly enhanced relative to un-catalyzed events at the same sites.

Targeting double-strand breaks to user-defined genomic locations greatly enhances DNA repair event rates relative to uncatalyzed events at the same sites.

By targeting double-strand breaks to user-defined locations, the rates of DNA repair events are greatly enhanced relative to un-catalyzed events at the same sites.

The review covers the use of vivo-MOs and genome editing tools in sea urchin studies since publication of the sea urchin genome in 2006 and discusses applications and potential of CRISPR/Cas9 in studying sea urchin development.

Here, we review the use of vivo-MOs and genome editing tools in sea urchin studies since the publication of its genome in 2006. Various applications of the CRISPR/Cas9 system and their potential in studying sea urchin development are also discussed.

The review covers the use of vivo-MOs and genome editing tools in sea urchin studies since publication of the sea urchin genome in 2006 and discusses applications and potential of CRISPR/Cas9 in studying sea urchin development.

Here, we review the use of vivo-MOs and genome editing tools in sea urchin studies since the publication of its genome in 2006. Various applications of the CRISPR/Cas9 system and their potential in studying sea urchin development are also discussed.

The review covers the use of vivo-MOs and genome editing tools in sea urchin studies since publication of the sea urchin genome in 2006 and discusses applications and potential of CRISPR/Cas9 in studying sea urchin development.

Here, we review the use of vivo-MOs and genome editing tools in sea urchin studies since the publication of its genome in 2006. Various applications of the CRISPR/Cas9 system and their potential in studying sea urchin development are also discussed.

The review covers the use of vivo-MOs and genome editing tools in sea urchin studies since publication of the sea urchin genome in 2006 and discusses applications and potential of CRISPR/Cas9 in studying sea urchin development.

Here, we review the use of vivo-MOs and genome editing tools in sea urchin studies since the publication of its genome in 2006. Various applications of the CRISPR/Cas9 system and their potential in studying sea urchin development are also discussed.

The review covers the use of vivo-MOs and genome editing tools in sea urchin studies since publication of the sea urchin genome in 2006 and discusses applications and potential of CRISPR/Cas9 in studying sea urchin development.

Here, we review the use of vivo-MOs and genome editing tools in sea urchin studies since the publication of its genome in 2006. Various applications of the CRISPR/Cas9 system and their potential in studying sea urchin development are also discussed.

The review covers the use of vivo-MOs and genome editing tools in sea urchin studies since publication of the sea urchin genome in 2006 and discusses applications and potential of CRISPR/Cas9 in studying sea urchin development.

Here, we review the use of vivo-MOs and genome editing tools in sea urchin studies since the publication of its genome in 2006. Various applications of the CRISPR/Cas9 system and their potential in studying sea urchin development are also discussed.

The review covers the use of vivo-MOs and genome editing tools in sea urchin studies since publication of the sea urchin genome in 2006 and discusses applications and potential of CRISPR/Cas9 in studying sea urchin development.

Here, we review the use of vivo-MOs and genome editing tools in sea urchin studies since the publication of its genome in 2006. Various applications of the CRISPR/Cas9 system and their potential in studying sea urchin development are also discussed.

The review focuses on diversity of nuclease domains for genome editing and on biochemical properties and applications best suited to each domain.

Here, we focus on the diversity of nuclease domains available for genome editing, highlighting biochemical properties and the potential applications that are best suited to each domain.

The review focuses on diversity of nuclease domains for genome editing and on biochemical properties and applications best suited to each domain.

Here, we focus on the diversity of nuclease domains available for genome editing, highlighting biochemical properties and the potential applications that are best suited to each domain.

The review focuses on diversity of nuclease domains for genome editing and on biochemical properties and applications best suited to each domain.

Here, we focus on the diversity of nuclease domains available for genome editing, highlighting biochemical properties and the potential applications that are best suited to each domain.

The review focuses on diversity of nuclease domains for genome editing and on biochemical properties and applications best suited to each domain.

Here, we focus on the diversity of nuclease domains available for genome editing, highlighting biochemical properties and the potential applications that are best suited to each domain.

The review focuses on diversity of nuclease domains for genome editing and on biochemical properties and applications best suited to each domain.

Here, we focus on the diversity of nuclease domains available for genome editing, highlighting biochemical properties and the potential applications that are best suited to each domain.

The review focuses on diversity of nuclease domains for genome editing and on biochemical properties and applications best suited to each domain.

Here, we focus on the diversity of nuclease domains available for genome editing, highlighting biochemical properties and the potential applications that are best suited to each domain.

Programmable site-specific nucleases including ZFNs, TALENs, meganucleases, and CRISPR-associated proteins have enabled and accelerated genome editing.

Breakthroughs in the development of programmable site-specific nucleases, including zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), meganucleases (MNs), and most recently, the clustered regularly interspaced short palindromic repeats (CRISPR) associated proteins (including Cas9) have greatly enabled and accelerated genome editing.

Programmable site-specific nucleases including ZFNs, TALENs, meganucleases, and CRISPR-associated proteins have enabled and accelerated genome editing.

Breakthroughs in the development of programmable site-specific nucleases, including zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), meganucleases (MNs), and most recently, the clustered regularly interspaced short palindromic repeats (CRISPR) associated proteins (including Cas9) have greatly enabled and accelerated genome editing.

Programmable site-specific nucleases including ZFNs, TALENs, meganucleases, and CRISPR-associated proteins have enabled and accelerated genome editing.

Breakthroughs in the development of programmable site-specific nucleases, including zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), meganucleases (MNs), and most recently, the clustered regularly interspaced short palindromic repeats (CRISPR) associated proteins (including Cas9) have greatly enabled and accelerated genome editing.

Programmable site-specific nucleases including ZFNs, TALENs, meganucleases, and CRISPR-associated proteins have enabled and accelerated genome editing.

Breakthroughs in the development of programmable site-specific nucleases, including zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), meganucleases (MNs), and most recently, the clustered regularly interspaced short palindromic repeats (CRISPR) associated proteins (including Cas9) have greatly enabled and accelerated genome editing.

Programmable site-specific nucleases including ZFNs, TALENs, meganucleases, and CRISPR-associated proteins have enabled and accelerated genome editing.

Breakthroughs in the development of programmable site-specific nucleases, including zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), meganucleases (MNs), and most recently, the clustered regularly interspaced short palindromic repeats (CRISPR) associated proteins (including Cas9) have greatly enabled and accelerated genome editing.

Programmable site-specific nucleases including ZFNs, TALENs, meganucleases, and CRISPR-associated proteins have enabled and accelerated genome editing.

Breakthroughs in the development of programmable site-specific nucleases, including zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), meganucleases (MNs), and most recently, the clustered regularly interspaced short palindromic repeats (CRISPR) associated proteins (including Cas9) have greatly enabled and accelerated genome editing.

No single genome-editing nuclease is optimized for all possible applications.

No single genome-editing nuclease is optimized for all possible applications.

No single genome-editing nuclease is optimized for all possible applications.

No single genome-editing nuclease is optimized for all possible applications.

No single genome-editing nuclease is optimized for all possible applications.

No single genome-editing nuclease is optimized for all possible applications.

No single genome-editing nuclease is optimized for all possible applications.

No single genome-editing nuclease is optimized for all possible applications.

No single genome-editing nuclease is optimized for all possible applications.

No single genome-editing nuclease is optimized for all possible applications.

No single genome-editing nuclease is optimized for all possible applications.

No single genome-editing nuclease is optimized for all possible applications.

Antisense morpholino oligonucleotide microinjection into the egg is described as the most widely used approach for gene knockdown in sea urchin embryos.

Microinjection of antisense morpholino oligonucleotides (MOs) into the egg is the most widely used approach for gene knockdown in sea urchin embryos.

Antisense morpholino oligonucleotide microinjection into the egg is described as the most widely used approach for gene knockdown in sea urchin embryos.

Microinjection of antisense morpholino oligonucleotides (MOs) into the egg is the most widely used approach for gene knockdown in sea urchin embryos.

Antisense morpholino oligonucleotide microinjection into the egg is described as the most widely used approach for gene knockdown in sea urchin embryos.

Microinjection of antisense morpholino oligonucleotides (MOs) into the egg is the most widely used approach for gene knockdown in sea urchin embryos.

Antisense morpholino oligonucleotide microinjection into the egg is described as the most widely used approach for gene knockdown in sea urchin embryos.

Microinjection of antisense morpholino oligonucleotides (MOs) into the egg is the most widely used approach for gene knockdown in sea urchin embryos.

Antisense morpholino oligonucleotide microinjection into the egg is described as the most widely used approach for gene knockdown in sea urchin embryos.

Microinjection of antisense morpholino oligonucleotides (MOs) into the egg is the most widely used approach for gene knockdown in sea urchin embryos.

Antisense morpholino oligonucleotide microinjection into the egg is described as the most widely used approach for gene knockdown in sea urchin embryos.

Microinjection of antisense morpholino oligonucleotides (MOs) into the egg is the most widely used approach for gene knockdown in sea urchin embryos.

Antisense morpholino oligonucleotide microinjection into the egg is described as the most widely used approach for gene knockdown in sea urchin embryos.

Microinjection of antisense morpholino oligonucleotides (MOs) into the egg is the most widely used approach for gene knockdown in sea urchin embryos.

ZFNs, TALENs, and CRISPR/Cas are molecular tools for DNA manipulation that have revolutionized genome editing.

Development of molecular tools for DNA manipulation, such as zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and the clustered regularly-interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas), has revolutionized genome editing.

ZFNs, TALENs, and CRISPR/Cas are molecular tools for DNA manipulation that have revolutionized genome editing.

Development of molecular tools for DNA manipulation, such as zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and the clustered regularly-interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas), has revolutionized genome editing.

ZFNs, TALENs, and CRISPR/Cas are molecular tools for DNA manipulation that have revolutionized genome editing.

Development of molecular tools for DNA manipulation, such as zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and the clustered regularly-interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas), has revolutionized genome editing.

ZFNs, TALENs, and CRISPR/Cas are molecular tools for DNA manipulation that have revolutionized genome editing.

Development of molecular tools for DNA manipulation, such as zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and the clustered regularly-interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas), has revolutionized genome editing.

ZFNs, TALENs, and CRISPR/Cas are molecular tools for DNA manipulation that have revolutionized genome editing.

Development of molecular tools for DNA manipulation, such as zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and the clustered regularly-interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas), has revolutionized genome editing.

ZFNs, TALENs, and CRISPR/Cas are molecular tools for DNA manipulation that have revolutionized genome editing.

Development of molecular tools for DNA manipulation, such as zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and the clustered regularly-interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas), has revolutionized genome editing.

ZFNs, TALENs, and CRISPR/Cas are molecular tools for DNA manipulation that have revolutionized genome editing.

Development of molecular tools for DNA manipulation, such as zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and the clustered regularly-interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas), has revolutionized genome editing.

CRISPR/Cas9 is described as a genome editing system that interrupts gene expression through cleavage of target DNA.

The bacterial Type II Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 genome editing system is the latest method of interrupting gene expression through cleavage of target DNA.

siRNAs are described as a method for transient downregulation of target gene expression through the RNA interference pathway.

Short-interfering RNAs (siRNAs) are one method of transiently down regulating the expression of any target gene through the exploitation of the RNA interference pathway

siRNAs are described as a method for transient downregulation of target gene expression through the RNA interference pathway.

Short-interfering RNAs (siRNAs) are one method of transiently down regulating the expression of any target gene through the exploitation of the RNA interference pathway

siRNAs are described as a method for transient downregulation of target gene expression through the RNA interference pathway.

Short-interfering RNAs (siRNAs) are one method of transiently down regulating the expression of any target gene through the exploitation of the RNA interference pathway

siRNAs are described as a method for transient downregulation of target gene expression through the RNA interference pathway.

Short-interfering RNAs (siRNAs) are one method of transiently down regulating the expression of any target gene through the exploitation of the RNA interference pathway

siRNAs are described as a method for transient downregulation of target gene expression through the RNA interference pathway.

Short-interfering RNAs (siRNAs) are one method of transiently down regulating the expression of any target gene through the exploitation of the RNA interference pathway

siRNAs are described as a method for transient downregulation of target gene expression through the RNA interference pathway.

Short-interfering RNAs (siRNAs) are one method of transiently down regulating the expression of any target gene through the exploitation of the RNA interference pathway

siRNAs are described as a method for transient downregulation of target gene expression through the RNA interference pathway.

Short-interfering RNAs (siRNAs) are one method of transiently down regulating the expression of any target gene through the exploitation of the RNA interference pathway

TALENs are described as artificial systems that can be designed and constructed relatively quickly to bind practically anywhere in the genome and cleave double-stranded DNA, thereby interrupting expression of a target gene.

Transcription activator-like effector nucleases (TALENs) are artificial systems that can be designed and constructed relatively quickly to bind practically anywhere in the genome and cleave double stranded DNA, thus interrupting the expression of any given target gene

TALENs are described as artificial systems that can be designed and constructed relatively quickly to bind practically anywhere in the genome and cleave double-stranded DNA, thereby interrupting expression of a target gene.

Transcription activator-like effector nucleases (TALENs) are artificial systems that can be designed and constructed relatively quickly to bind practically anywhere in the genome and cleave double stranded DNA, thus interrupting the expression of any given target gene

TALENs are described as artificial systems that can be designed and constructed relatively quickly to bind practically anywhere in the genome and cleave double-stranded DNA, thereby interrupting expression of a target gene.

Transcription activator-like effector nucleases (TALENs) are artificial systems that can be designed and constructed relatively quickly to bind practically anywhere in the genome and cleave double stranded DNA, thus interrupting the expression of any given target gene

TALENs are described as artificial systems that can be designed and constructed relatively quickly to bind practically anywhere in the genome and cleave double-stranded DNA, thereby interrupting expression of a target gene.

Transcription activator-like effector nucleases (TALENs) are artificial systems that can be designed and constructed relatively quickly to bind practically anywhere in the genome and cleave double stranded DNA, thus interrupting the expression of any given target gene

TALENs are described as artificial systems that can be designed and constructed relatively quickly to bind practically anywhere in the genome and cleave double-stranded DNA, thereby interrupting expression of a target gene.

Transcription activator-like effector nucleases (TALENs) are artificial systems that can be designed and constructed relatively quickly to bind practically anywhere in the genome and cleave double stranded DNA, thus interrupting the expression of any given target gene

TALENs are described as artificial systems that can be designed and constructed relatively quickly to bind practically anywhere in the genome and cleave double-stranded DNA, thereby interrupting expression of a target gene.

Transcription activator-like effector nucleases (TALENs) are artificial systems that can be designed and constructed relatively quickly to bind practically anywhere in the genome and cleave double stranded DNA, thus interrupting the expression of any given target gene

TALENs are described as artificial systems that can be designed and constructed relatively quickly to bind practically anywhere in the genome and cleave double-stranded DNA, thereby interrupting expression of a target gene.

Transcription activator-like effector nucleases (TALENs) are artificial systems that can be designed and constructed relatively quickly to bind practically anywhere in the genome and cleave double stranded DNA, thus interrupting the expression of any given target gene

The abstract states that CRISPR/Cas9 has effectiveness at cleaving genomic DNA in mammalian cells in vitro and in vivo, exhibits specificity, and is relatively easy to construct in targeted forms.

Its effectiveness at cleaving genomic DNA in mammalian cells in vitro and in vivo [2, 3], the specificity that this system exhibits [4, 5] and the relative ease with which targeted systems can be constructed

CRISPR/Cas technology has seen substantial recent progress, including technical improvements and wide application in many model systems.

In the last few years, substantial progress has been made in CRISPR/Cas technology, including technical improvements and wide application in many model systems.

This review focuses on four common gene-therapy-related modalities used to alter gene expression: siRNAs, TALENs, ZFNs, and CRISPR/Cas9.

Within this review we focus on 4 of the more common forms of gene therapy utilised to alter gene expression; siRNAs, TALENs, ZFNs and CRISPR/Cas9.

This review focuses on four common gene-therapy-related modalities used to alter gene expression: siRNAs, TALENs, ZFNs, and CRISPR/Cas9.

Within this review we focus on 4 of the more common forms of gene therapy utilised to alter gene expression; siRNAs, TALENs, ZFNs and CRISPR/Cas9.

This review focuses on four common gene-therapy-related modalities used to alter gene expression: siRNAs, TALENs, ZFNs, and CRISPR/Cas9.

Within this review we focus on 4 of the more common forms of gene therapy utilised to alter gene expression; siRNAs, TALENs, ZFNs and CRISPR/Cas9.

This review focuses on four common gene-therapy-related modalities used to alter gene expression: siRNAs, TALENs, ZFNs, and CRISPR/Cas9.

Within this review we focus on 4 of the more common forms of gene therapy utilised to alter gene expression; siRNAs, TALENs, ZFNs and CRISPR/Cas9.

This review focuses on four common gene-therapy-related modalities used to alter gene expression: siRNAs, TALENs, ZFNs, and CRISPR/Cas9.

Within this review we focus on 4 of the more common forms of gene therapy utilised to alter gene expression; siRNAs, TALENs, ZFNs and CRISPR/Cas9.

This review focuses on four common gene-therapy-related modalities used to alter gene expression: siRNAs, TALENs, ZFNs, and CRISPR/Cas9.

Within this review we focus on 4 of the more common forms of gene therapy utilised to alter gene expression; siRNAs, TALENs, ZFNs and CRISPR/Cas9.

This review focuses on four common gene-therapy-related modalities used to alter gene expression: siRNAs, TALENs, ZFNs, and CRISPR/Cas9.

Within this review we focus on 4 of the more common forms of gene therapy utilised to alter gene expression; siRNAs, TALENs, ZFNs and CRISPR/Cas9.

These genome editing approaches can be used to develop potential therapeutic strategies to treat heritable diseases.

These approaches can be used to develop potential therapeutic strategies to effectively treat heritable diseases.

These genome editing approaches can be used to develop potential therapeutic strategies to treat heritable diseases.

These approaches can be used to develop potential therapeutic strategies to effectively treat heritable diseases.

These genome editing approaches can be used to develop potential therapeutic strategies to treat heritable diseases.

These approaches can be used to develop potential therapeutic strategies to effectively treat heritable diseases.

These genome editing approaches can be used to develop potential therapeutic strategies to treat heritable diseases.

These approaches can be used to develop potential therapeutic strategies to effectively treat heritable diseases.

These genome editing approaches can be used to develop potential therapeutic strategies to treat heritable diseases.

These approaches can be used to develop potential therapeutic strategies to effectively treat heritable diseases.

These genome editing approaches can be used to develop potential therapeutic strategies to treat heritable diseases.

These approaches can be used to develop potential therapeutic strategies to effectively treat heritable diseases.

These genome editing approaches can be used to develop potential therapeutic strategies to treat heritable diseases.

These approaches can be used to develop potential therapeutic strategies to effectively treat heritable diseases.

ZFN and TALEN provided sequence-specific gene-editing capacity but their broad utility was limited by laborious nuclease design and synthesis, limited target choices, and poor editing efficiency.

While these approaches provided sequence-specific gene-editing capacity, the laborious process of designing and synthesizing recombinant nucleases to recognize a specific target sequence, combined with limited target choices and poor editing efficiency, ultimately minimized the broad utility of these systems.

Source: Exploiting DNA Endonucleases to Advance Mechanisms of DNA Repair

Zinc-finger nucleases, TALENs, and CRISPR/Cas9 are described as providing methods for gene knockout in sea urchins.

Recent advances in genome editing tools, such as zinc-finger nucleases, transcription activator-like effector-based nucleases and the ... CRISPR/Cas9 system, have provided methods for gene knockout in sea urchins.

Source: Recent advances in functional perturbation and genome editing techniques in studying sea urchin development

The biology of each genome-editing nuclease influences targeting potential, off-target cleavage spectrum, ease of use, and the types of recombination events produced at targeted double-strand breaks.

However, the underlying biology of each genome-editing nuclease influences the targeting potential, the spectrum of off-target cleavages, the ease-of-use, and the types of recombination events at targeted double-strand breaks.

Source: Applications of Alternative Nucleases in the Age of CRISPR/Cas9

Targeting double-strand breaks to user-defined genomic locations greatly enhances DNA repair event rates relative to uncatalyzed events at the same sites.

By targeting double-strand breaks to user-defined locations, the rates of DNA repair events are greatly enhanced relative to un-catalyzed events at the same sites.

Source: Applications of Alternative Nucleases in the Age of CRISPR/Cas9

The review focuses on diversity of nuclease domains for genome editing and on biochemical properties and applications best suited to each domain.

Here, we focus on the diversity of nuclease domains available for genome editing, highlighting biochemical properties and the potential applications that are best suited to each domain.

Source: Applications of Alternative Nucleases in the Age of CRISPR/Cas9

Programmable site-specific nucleases including ZFNs, TALENs, meganucleases, and CRISPR-associated proteins have enabled and accelerated genome editing.

Breakthroughs in the development of programmable site-specific nucleases, including zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), meganucleases (MNs), and most recently, the clustered regularly interspaced short palindromic repeats (CRISPR) associated proteins (including Cas9) have greatly enabled and accelerated genome editing.

Source: Applications of Alternative Nucleases in the Age of CRISPR/Cas9

No single genome-editing nuclease is optimized for all possible applications.

No single genome-editing nuclease is optimized for all possible applications.

Source: Applications of Alternative Nucleases in the Age of CRISPR/Cas9

ZFNs, TALENs, and CRISPR/Cas are molecular tools for DNA manipulation that have revolutionized genome editing.

Development of molecular tools for DNA manipulation, such as zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and the clustered regularly-interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas), has revolutionized genome editing.

Source: Genome Editing and Its Applications in Model Organisms

TALENs are described as artificial systems that can be designed and constructed relatively quickly to bind practically anywhere in the genome and cleave double-stranded DNA, thereby interrupting expression of a target gene.

Transcription activator-like effector nucleases (TALENs) are artificial systems that can be designed and constructed relatively quickly to bind practically anywhere in the genome and cleave double stranded DNA, thus interrupting the expression of any given target gene

Source: A Review of Personalised Molecular Medicine for the Treatment of Corneal Disorders

This review focuses on four common gene-therapy-related modalities used to alter gene expression: siRNAs, TALENs, ZFNs, and CRISPR/Cas9.

Within this review we focus on 4 of the more common forms of gene therapy utilised to alter gene expression; siRNAs, TALENs, ZFNs and CRISPR/Cas9.

Source: A Review of Personalised Molecular Medicine for the Treatment of Corneal Disorders

These genome editing approaches can be used to develop potential therapeutic strategies to treat heritable diseases.

These approaches can be used to develop potential therapeutic strategies to effectively treat heritable diseases.

Source: Genome Editing and Its Applications in Model Organisms